홈 > 시장보고서 > 의료기기 > 체외진단

시장보고서

상품코드

1780324

감염증 체외진단약 시장 규모와 예측(2021-2031년) : 세계 및 지역 점유율, 동향, 성장 기회 분석 리포트 - 용도, 최종사용자, 지역별

Infectious Disease In vitro Diagnostics Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography

발행일: 2025년 07월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 190 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감염증 체외진단약 시장 규모는 2024년 456억 9,000만 달러에서 2031년에는 767억 1,000만 달러로 성장할 것으로 예측되고 있으며, 2025-2031년 CAGR은 7.7%로 예측됩니다. 감염병 유행 증가와 주요 기업의 전략적 개발은 감염병 체외진단제 시장 규모 확대에 기여하는 주목할 만한 요인입니다. 그러나 불충분한 상환 시나리오가 감염성 체외진단 시장 성장을 저해하고 있습니다.

분자진단약과 자동화 시스템의 개발 및 통합을 포함한 기술 발전은 감염성 질환 검출의 정확성, 속도, 접근성을 향상시킵니다. 아래는 그 한 예이다:

2024년 6월, MP Biomedicals는 헬리코박터 파일로리, 살모넬라, 콜레라균에 대한 신속한 면역크로마토그래피 분석의 새로운 라인을 발표했습니다.

2024년 6월, 로슈는 SARS-CoV-2, 인플루엔자 A/B, RSV를 동시에 검출할 수 있도록 업데이트된 cobas liat multiplex PCR panel의 FDA 긴급사용승인(EUA)을 획득하여 20분 이내로 증상 호흡기 감염증을 관리할 수 있게 되었습니다.

2024년 7월, 셜록 바이오사이언스는 2025년 출시를 목표로 2024년 5월에 CRISPR 기반 임질 및 클라미디아 일반의약품(OTC) 검사에 대한 임상시험을 시작했습니다. 또한 AI와 나노테크놀러지을 통한 머신러닝을 통합한 APEX-TB도 출시되어 휴대용 기기를 이용한 정확한 실시간 분자진단을 제공합니다.

2024년 6월, QIAGEN은 디지털 PCR(dPCR) 플랫폼 QIAcuity에 35종의 습식 실험실 테스트를 거친 디지털 PCR 미생물 DNA 검출 분석법을 새로 도입하여 미생물 연구 역량을 대폭 강화했습니다.

이러한 발전은 감염병 치료의 미래를 이끌 분산형, 사용자 중심, 빠른 진단 기술을 향한 큰 움직임의 일부입니다. 이는 향후 수년간 감염 체외진단 시장 성장에 기여할 것으로 예측됩니다.

최종사용자별 인사이트

감염 체외진단 시장은 최종사용자별로 병원 및 클리닉, 진단연구소, 혈액은행, 기타로 구분됩니다. 2024년 감염성 체외진단 시장 점유율은 병원 및 클리닉이 가장 큰 비중을 차지했습니다. 라싸열, 콜레라, 결핵, 말라리아 등의 빈번한 발생으로 병원 및 진료소에서 정확하고 신속한 진단의 필요성이 꾸준히 증가하고 있습니다. 환자 수가 급증하고 양질의 의료에 대한 수요가 증가함에 따라 병원은 분자진단법을 포함한 보다 진보된 진단 툴을 도입하고 있습니다. 정부 자금 증가, 기증자 지원, 2, 3차 병원의 인프라 구축은 IVD 제품의 채택을 더욱 촉진하고 있습니다. 병원 프로토콜에 체외진단용 의약품을 통합하면 환자 예후를 개선하고 불필요한 항생제 사용을 줄이며, 도시 및 농촌 보건소에서의 감염 관리를 확실히 개선할 수 있으므로 감염 체외진단용 의약품 시장의 성장에 박차를 가할 수 있습니다.

세계보건기구(WHO) 및 멕시코 보건부 국립호흡기질환연구소는 감염성 체외진단 시장 보고서 작성시 참고한 1차 정보 및 2차 정보 중 하나입니다.

감염증 체외진단약 시장 - 주요 시장 역학
시장 성장 촉진요인
- 감염증 이환율의 증가
- 주요 기업에 의한 전략적 발전
시장 성장 억제요인
- 불충분한 상환 시나리오
시장 기회
- 감염증에 대한 인식을 높이기 위한 정부 구상
향후 동향
- 기술의 진보
촉진요인과 억제요인의 영향

제6장 감염증 체외진단약 시장 : 세계 시장 분석

감염증 체외진단약 시장 매출, 2021-2031년
감염증 체외진단약 시장 예측 분석

제7장 감염증 체외진단약 시장 분석 - 용도별

HIV 또는 에이즈
결핵
B형 및 C형 간염
말라리아
기타

제8장 감염증 체외진단약 시장 분석 - 최종사용자별

병원 및 진료소
진단 연구소
혈액은행
기타

제9장 감염증 체외진단약 시장 분석 - 지역별

북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양의 기타 국가
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제10장 경쟁 구도

주요 기업에 의한 히트맵 분석
기업의 포지셔닝과 집중도

제11장 업계 상황

세계의 감염증 체외진단약 시장에서 성장 전략
유기적 성장 전략
무기적 성장 전략

제12장 기업 개요

ABBOTT LABORATORIES
F. HOFFMANN-LA ROCHE LTD
BECTON DICKINSON AND CO
SYSMEX CORP
BIOMERIEUX SA
BIO-RAD LABORATORIES INC
QIAGEN NV
QUIDELORTHO CORP
BRUKER CORP
DANAHER CORP

제13장 부록

KSA 25.08.07

The infectious disease in vitro diagnostics market size is expected to grow from US$ 45.69 billion in 2024 to US$ 76.71 billion by 2031; it is projected to register a CAGR of 7.7% during 2025-2031. The increasing prevalence of infectious diseases and strategic developments by key players are noteworthy factors contributing to the expansion of the infectious disease in vitro diagnostics market size. However, the inadequate reimbursement scenario hinders the infectious disease in vitro diagnostics market growth.

Technological advancements involving the development and integration of molecular diagnostics and automation systems enhance the accuracy, speed, and accessibility of infectious disease detection. Below are a few instances:

In June 2024, MP Biomedicals introduced a new line of rapid immunochromatographic assays for Helicobacter pylori, Salmonella typhi, and Vibrio cholerae, intended for point-of-care in resource-constrained environments.

In June 2024, Roche gained FDA Emergency Use Authorization (EUA) for its cobas liat multiplex PCR panel updated to detect SARS-CoV-2, influenza A/B, and RSV simultaneously, advancing syndromic respiratory infection management in less than 20 minutes.

In July 2024, Sherlock Biosciences initiated clinical trials for its CRISPR-based over-the-counter (OTC) test for gonorrhea and chlamydia in May 2024, with an eye toward a 2025 launch. APEX-TB, integrating machine learning from AI and nanotechnology, was also launched to provide accurate, real-time molecular diagnostics using portable devices.

In June 2024, QIAGEN introduced 35 new wet-lab tested digital PCR Microbial DNA Detection Assays to its digital PCR (dPCR) platform QIAcuity, noticeably strengthening its capabilities in microbial research.

These advancements are part of a larger movement toward decentralized, user-centric, and fast diagnostic technologies guiding the future of infectious disease care. This is expected to contribute to the growth of the infectious disease in vitro diagnostics market in the coming years.

End User -Based Insights

Based on end user, the infectious disease in vitro diagnostics market is segmented into hospitals and clinics, diagnostics laboratories, blood bank, and others. The hospitals and clinics segment held the largest infectious disease in vitro diagnostics market share in 2024. The need for accurate, timely diagnosis in hospitals and clinics is rising steadily due to frequent outbreaks of Lassa fever, cholera, tuberculosis, and malaria. The soaring patient load and demand for quality care have pushed hospitals to adopt more sophisticated diagnostic tools, including molecular diagnostics. Increased government funding, donor support, and infrastructure improvements in secondary and tertiary hospitals further boost the adoption of IVD products. Integrating IVD in hospital protocols improves patient outcomes, reduces unnecessary antibiotic use, and ensures better management of infectious diseases in urban and rural health centers, thereby fueling the infectious disease in vitro diagnostics market growth.

The World Health Organization and Mexico's Ministry of Health's National Institute of Respiratory Diseases are among the primary and secondary sources referred to while preparing the infectious disease in vitro diagnostics market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Infectious Disease In vitro Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Infectious Disease In vitro Diagnostics Market - Key Market Dynamics

5.1 Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Infectious Diseases
- 5.2.2 Strategic Developments by Key Players
5.3 Market Restraints
- 5.3.1 Inadequate Reimbursement Scenario
5.4 Market Opportunities
- 5.4.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
5.5 Future Trends
- 5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Infectious Disease In vitro Diagnostics Market - Global Market Analysis

6.1 Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Infectious Disease In vitro Diagnostics Market Forecast Analysis

7. Infectious Disease In vitro Diagnostics Market Analysis - by Applications

7.1 HIV or AIDS
- 7.1.1 Overview
- 7.1.2 HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Tuberculosis
- 7.2.1 Overview
- 7.2.2 Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Hepatitis B and C
- 7.3.1 Overview
- 7.3.2 Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Malaria
- 7.4.1 Overview
- 7.4.2 Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

8. Infectious Disease In vitro Diagnostics Market Analysis - by End User

8.1 Hospitals and Clinics
- 8.1.1 Overview
- 8.1.2 Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Blood Bank
- 8.3.1 Overview
- 8.3.2 Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

9. Infectious Disease In vitro Diagnostics Market - Geographical Analysis

9.1 Overview
9.2 North America
- 9.2.1 North America Infectious Disease In vitro Diagnostics Market Overview
- 9.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  - 9.2.2.1 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
  - 9.2.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.2.3 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.2.3.1 United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.2.3.1.1 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.2.3.1.2 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.2.3.2 Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.2.3.2.1 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.2.3.2.2 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.2.3.3 Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.2.3.3.1 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.2.3.3.2 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3 Europe
- 9.3.1 Europe Infectious Disease In vitro Diagnostics Market Overview
- 9.3.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  - 9.3.2.1 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
  - 9.3.2.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.3.3 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.3.3.1 United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.1.1 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.1.2 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.3.3.2 Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.2.1 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.2.2 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.3.3.3 France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.3.1 France: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.3.2 France: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.3.3.4 Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.4.1 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.4.2 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.3.3.5 Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.5.1 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.5.2 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.3.3.6 Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.3.3.6.1 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.3.3.6.2 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4 Asia Pacific
- 9.4.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Overview
- 9.4.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  - 9.4.2.1 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
  - 9.4.2.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.4.3 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.4.3.1 China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.1.1 China: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.1.2 China: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.4.3.2 Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.2.1 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.2.2 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.4.3.3 India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.3.1 India: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.3.2 India: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.4.3.4 Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.4.1 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.4.2 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.4.3.5 South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.5.1 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.5.2 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.4.3.6 Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.4.3.6.1 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.4.3.6.2 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
- 9.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market Overview
- 9.5.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  - 9.5.2.1 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
  - 9.5.2.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.5.3 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.1 South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.5.3.1.1 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.5.3.1.2 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.5.3.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.5.3.2.1 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.5.3.2.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.5.3.3 United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.5.3.3.1 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.5.3.3.2 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.5.3.4 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.5.3.4.1 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.5.3.4.2 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.6 South and Central America
- 9.6.1 South and Central America Infectious Disease In vitro Diagnostics Market Overview
- 9.6.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  - 9.6.2.1 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
  - 9.6.2.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.6.3 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.6.3.1 Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.6.3.1.1 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.6.3.1.2 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.6.3.2 Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.6.3.2.1 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.6.3.2.2 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  - 9.6.3.3 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.6.3.3.1 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
    - 9.6.3.3.2 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
11.3 Organic Growth Strategies
- 112.3.1 Overview
11.4 Inorganic Growth Strategies
- 112.4.1 Overview

12. Company Profiles

12.1. ABBOTT LABORATORIES
- 12.1.1. Key Facts
- 12.1.2. Business Description
- 12.1.3. Products and Services
- 12.1.4. Financial Overview
- 12.1.5. SWOT Analysis
- 12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD
- 12.2.1. Key Facts
- 12.2.2. Business Description
- 12.2.3. Products and Services
- 12.2.4. Financial Overview
- 12.2.5. SWOT Analysis
- 12.2.6. Key Developments
12.3. BECTON DICKINSON AND CO
- 12.3.1. Key Facts
- 12.3.2. Business Description
- 12.3.3. Products and Services
- 12.3.4. Financial Overview
- 12.3.5. SWOT Analysis
- 12.3.6. Key Developments
12.4. SYSMEX CORP
- 12.4.1. Key Facts
- 12.4.2. Business Description
- 12.4.3. Products and Services
- 12.4.4. Financial Overview
- 12.4.5. SWOT Analysis
12.5. BIOMERIEUX SA
- 12.5.1. Key Facts
- 12.5.2. Business Description
- 12.5.3. Products and Services
- 12.5.4. Financial Overview
- 12.5.5. SWOT Analysis
- 12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES INC
- 12.6.1. Key Facts
- 12.6.2. Business Description
- 12.6.3. Products and Services
- 12.6.4. Financial Overview
- 12.6.5. SWOT Analysis
- 12.6.6. Key Developments
12.6. QIAGEN NV
- 12.6.1. Key Facts
- 12.6.2. Business Description
- 12.6.3. Products and Services
- 12.6.4. Financial Overview
- 12.6.5. SWOT Analysis
- 12.6.6. Key Developments
12.8. QUIDELORTHO CORP
- 12.8.1. Key Facts
- 12.8.2. Business Description
- 12.8.3. Products and Services
- 12.8.4. Financial Overview
- 12.8.5. SWOT Analysis
- 12.8.6. Key Developments
12.9. BRUKER CORP
- 12.9.1. Key Facts
- 12.9.2. Business Description
- 12.9.3. Products and Services
- 12.9.4. Financial Overview
- 12.9.5. SWOT Analysis
- 12.9.6. Key Developments
12.10. DANAHER CORP
- 12.10.1. Key Facts
- 12.10.2. Business Description
- 12.10.3. Products and Services
- 12.10.4. Financial Overview
- 12.10.5. SWOT Analysis
- 12.10.6. Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,424,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,312,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 12,200,000

※ 부가세 별도